How the Alzheimer’s disease community is moving past amyloid
As the Alzheimer’s field is slowly taking on the search for new targets outside of the β amyloid and tau hypotheses, researchers are ramping up exploration of new pathways and looking to the disease’s genetics for clues. High on the list of emerging areas are mitochondrial factors, inflammasome targets and neuroprotection.
Moreover, lessons from oncology are driving the quest to find ways of using precision medicine to break the notion that Alzheimer’s is a single disease. ...
BCIQ Company Profiles
Alzheimer's Drug Discovery Foundation (ADDF)